Advertisement
Advertisement
U.S. markets close in 4 hours 50 minutes
Advertisement
Advertisement
Advertisement
Advertisement

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3800+0.0400 (+2.99%)
As of 11:10AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inverted Hammer

Inverted Hammer

Previous Close1.3400
Open1.3400
Bid1.3600 x 1200
Ask1.3800 x 900
Day's Range1.3400 - 1.3800
52 Week Range1.3400 - 4.4600
Volume28,442
Avg. Volume135,498
Market Cap37.896M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.5950
Earnings DateAug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CNSP

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CNS Pharmaceuticals, Inc.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    23 hours agoMorningstar
View more
Advertisement
Advertisement